The molecular evaluation of thioredoxin (TXN1 & TXN2), thioredoxin reductase 1 (TXNRd1), and oxidative stress markers in a binary rat model of hypo- and hyperthyroidism after treatment with gallic acid.

Najafi, Zohreh; Chamani, Elham; Zarban, Asghar; Rezaei, Zohreh; Sharifzadeh, Gholamreza

Najafi, Zohreh; Chamani, Elham; Zarban, Asghar; Rezaei, Zohreh; Sharifzadeh, Gholamreza.

Affiliation

Najafi Z; Department of Clinical Biochemistry, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran.
Chamani E; Department of Clinical Biochemistry, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran.
Zarban A; Department of Clinical Biochemistry, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran.
Rezaei Z; Department of Biology, University of Sistan and Baluchestan, Zahedan, Iran.
Sharifzadeh G; Social Determinants of Health Research Center, Birjand University of Medical Sciences, Birjand, Iran.

Drug Chem Toxicol ; 46(6): 1108-1115, 2023 Nov.

Article de En | MEDLINE | ID: mdl-36314079

Sujet(s)
Mots clés

Gallic acid; hyperthyroidism; hypothyroidism; oxidative stress; thioredoxin

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Hyperthyroïdie / Hypothyroïdie Limites: Animals Langue: En Journal: Drug Chem Toxicol Année: 2023 Type de document: Article Pays d'affiliation: Iran Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google